AHA participated today in a stakeholder listening session hosted by Centers for Medicare & Medicaid Services Administrator Seema Verma to formally launch the agency’s regulatory relief effort. AHA President and CEO Rick Pollack thanked the agency for recent actions to reduce the regulatory burden on health care providers, noting a new AHA report that found non-clinical regulatory requirements cost providers nearly $39 billion a year and divert clinicians from patient care. To further reduce this regulatory burden, he encouraged the agency to modernize “fraud and abuse rules” to allow hospitals and doctors to collaborate on additional innovative care models; align quality reporting across all its programs and focus on “measures that matter”; ensure hospitals are not penalized by audits that use unfair sampling methods to determine Medicare repayments; and expand and make more flexible Medicare coverage of telehealth services, among other actions. For more on how the scope and volume of regulatory requirements are diverting resources from the patient-centered mission of health systems, hospitals and post-acute care providers, visit www.aha.org/regrelief.

Headline
The American Medical Association Nov. 17 released its latest annual report on health insurance competition, which found that 95% of commercial markets were…
Headline
The Medicare Part A deductible for inpatient hospital services will increase by $40 in calendar year 2026 to $1,776, the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services Nov. 16 issued a proposed rule on program integrity oversight in Medicare, Medicaid, the Children’s Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 13 announced it will delay enforcement of its Medicaid community engagement requirements that are set for…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…